KOCAA
Knights of Columbus Asset Advisors’s Castle Biosciences CSTL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-25,133
| Closed | -$547K | – | 406 |
|
2024
Q2 | $547K | Hold |
25,133
| – | – | 0.04% | 289 |
|
2024
Q1 | $557K | Sell |
25,133
-81,129
| -76% | -$1.8M | 0.04% | 270 |
|
2023
Q4 | $2.29M | Buy |
106,262
+52,921
| +99% | +$1.14M | 0.15% | 222 |
|
2023
Q3 | $901K | Buy |
53,341
+27,470
| +106% | +$464K | 0.08% | 243 |
|
2023
Q2 | $355K | Buy |
25,871
+58
| +0.2% | +$796 | 0.03% | 288 |
|
2023
Q1 | $586K | Buy |
25,813
+22
| +0.1% | +$500 | 0.06% | 260 |
|
2022
Q4 | $607K | Sell |
25,791
-273
| -1% | -$6.43K | 0.06% | 248 |
|
2022
Q3 | $680K | Buy |
26,064
+3,201
| +14% | +$83.5K | 0.07% | 230 |
|
2022
Q2 | $502K | Hold |
22,863
| – | – | 0.05% | 249 |
|
2022
Q1 | $1.03M | Buy |
22,863
+261
| +1% | +$11.7K | 0.09% | 229 |
|
2021
Q4 | $969K | Buy |
22,602
+400
| +2% | +$17.1K | 0.08% | 229 |
|
2021
Q3 | $1.48M | Buy |
22,202
+118
| +0.5% | +$7.85K | 0.13% | 211 |
|
2021
Q2 | $1.62M | Buy |
22,084
+131
| +0.6% | +$9.6K | 0.15% | 209 |
|
2021
Q1 | $1.5M | Sell |
21,953
-5,393
| -20% | -$369K | 0.15% | 215 |
|
2020
Q4 | $1.84M | Buy |
27,346
+6,060
| +28% | +$407K | 0.2% | 187 |
|
2020
Q3 | $1.1M | Sell |
21,286
-13,917
| -40% | -$716K | 0.14% | 232 |
|
2020
Q2 | $1.33M | Buy |
+35,203
| New | +$1.33M | 0.16% | 206 |
|